Table 2.
No | HTL epitope | Position | Vaxijen Score | Allergenicity | Toxicity | Mutation | Final decision |
---|---|---|---|---|---|---|---|
1 | KVLRVLVTTTALLAA | 16–2 | − 0.2328 | No allergen | |||
2 | LRVLVTTTALLAAGA | 18–4 | − 0.0644 | No allergen | |||
3 | MKVLRVLVTTTALLA | 15–1 | − 0.1848 | No allergen | |||
4 | VLRVLVTTTALLAAG | 17–3 | − 0.2461 | No allergen | |||
5 | GNGDTLSIDGKNYQQ | 150–131 | 1.8936 | No allergen | * | ||
6 | LSIDGKNYQQAVPGQ | 155–141 | 1.1512 | Allergen | |||
7 | TLSIDGKNYQQAVPG | 154–140 | 1.1523 | Allergen | |||
8 | PWAQGLYIAAGAAYL | 125–111 | 0.5259 | No allergen | * | ||
9 | WAQGLYIAAGAAYLD | 126–112 | 0.4335 | No allergen | * | ||
10 | AQGLYIAAGAAYLDN | 127–113 | 0.4818 | No allergen | * | ||
11 | GLYIAAGAAYLDNDY | 129–115 | 0.4596 | No allergen | * | ||
12 | QGLYIAAGAAYLDND | 128–114 | 0.4293 | No allergen | * | ||
13 | ANEIRNDNKYEWMPV | 241–226 | 1.7000 | No allergen | * | ||
14 | GKMSYKNDIAPYLGF | 175–161 | 0.5176 | No allergen | * | ||
15 | KMSYKNDIAPYLGFG | 176–162 | 0.4967 | No allergen | * | ||
16 | RGKMSYKNDIAPYLG | 174–160 | 0.5852 | No allergen | * | ||
17 | VHDSYAFDKNQLIPV | 40–26 | − 0.1666 | No allergen | |||
18 | VRGKMSYKNDIAPYL | 173–159 | 0.7463 | Allergen | |||
19 | IRPWGASTNPWAQGL | 102–116 | − 0.1476 | No allergen | |||
20 | DIAPYLGFGFAPKIS | 168–182 | 1.2750 | No allergen | * | ||
21 | TALLAAGAAMADEAV | 11–25 | − 0.0024 | No allergen | |||
22 | NPWAQGLYIAAGAAY | 110–124 | 0.1204 | No allergen | |||
23 | PWAQGLYIAAGAAYL | 111–125 | 0.0259 | No allergen | |||
24 | VHDSYAFDKNQLIPV | 26–40 | − 0.1666 | Allergen | |||
25 | VLRVLVTTTALLAAG | 3–17 | − 0.2461 | Allergen | |||
26 | KVLRVLVTTTALLAA | 2–16 | − 0.2328 | Allergen | |||
27 | IAAGAAYLDNDYDLA | 118–132 | − 0.0341 | No allergen | |||
28 | NPWAQGLYIAAGAAY | 110–124 | 0.1204 | No allergen | |||
29 | TALLAAGAAMADEAV | 11–25 | − 0.0024 | No allergen | |||
30 | VLVTTTALLAAGAAM | 6–20 | − 0.0596 | No allergen | |||
31 | AAGAAYLDNDYDLAK | 119–133 | − 0.0505 | No allergen | |||
32 | LVTTTALLAAGAAMA | 7–21 | 0.0283 | Allergen | |||
33 | YLGFGFAPKISKNWG | 172–186 | 1.7184 | No allergen | * |
Eleven HTL epitopes were selected (labeled with *) for selective step to incorporation in the vaccine construct